hydralazine has been researched along with Carcinoma, Anaplastic in 3 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De la Cruz-Hernández, E | 1 |
| Perez-Plasencia, C | 1 |
| Pérez-Cardenas, E | 1 |
| Gonzalez-Fierro, A | 1 |
| Trejo-Becerril, C | 1 |
| Chávez-Blanco, A | 1 |
| Taja-Chayeb, L | 1 |
| Vidal, S | 1 |
| Gutiérrez, O | 1 |
| Dominguez, GI | 1 |
| Trujillo, JE | 1 |
| Duenas-González, A | 1 |
| PERRY, HM | 1 |
| Knowles, HJ | 1 |
| Tian, YM | 1 |
| Mole, DR | 1 |
| Harris, AL | 1 |
3 other studies available for hydralazine and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Transcriptional changes induced by epigenetic therapy with hydralazine and magnesium valproate in cervical carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Clinical Trials as Topic; DNA Methylation | 2011 |
CARCINOMA AND HYDRALAZINE TOXICITY IN PATIENTS WITH MALIGNANT HYPERTENSION.
Topics: Breast Neoplasms; Carcinoma; Humans; Hydralazine; Hypertension; Hypertension, Malignant; Lung Neopla | 1963 |
Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
Topics: Adrenomedullin; Angiogenesis Inducing Agents; Animals; Breast Neoplasms; Carcinoma; Carcinoma, Renal | 2004 |